Atlas Trials

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Clinical trial NCT03615144 · TERMINATED

Trial details

NCT number
NCT03615144
Sponsor
Memorial Sloan Kettering Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Malignant Hematologic Disorders
Start date
2018-07-23
Primary completion
2020-11-13
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.